Chorioamnionitis Alters the Response to Surfactant in Preterm Infants

Journal of Pediatrics

Volumn 156, Issue 1, 2010, Pages

  Been, Jasper V ^a   Rours, Ingrid G ^c,d   Kornelisse, René F ^e   Jonkers, Femke ^b   de Krijger, Ronald R ^c   Zimmermann, Luc J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Maasstad Hospital Rotterdam   (Netherlands)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; STEROID; SURFACTANT;

ARTICLE; ASSISTED VENTILATION; BIRTH WEIGHT; CHORIOAMNIONITIS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG FATALITY; EXTUBATION; FEMALE; GESTATIONAL AGE; HISTOLOGY; HUMAN; INFANT; INSPIRATORY CAPACITY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; NEWBORN PERIOD; OBSERVATIONAL STUDY; OXYGEN BREATHING; PREMATURITY; PRENATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVOR; TREATMENT RESPONSE;

EID: 72049125320     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.07.044     Document Type: Article

References (40)

1. Been J.V., and Zimmermann L.J. What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics. Eur J Pediatr 166 (2007) 889-899
2. Lahra M.M., and Jeffery H.E. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol 190 (2004) 147-151
3. Goldenberg R.L., Hauth J.C., and Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 342 (2000) 1500-1507
4. Redline R.W., Faye-Petersen O., Heller D., Qureshi F., Savell V., and Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 6 (2003) 435-448
5. Kramer B.W., Kallapur S., Newnham J., and Jobe A.H. Prenatal inflammation and lung development. Semin Fetal Neonatal Med 14 (2009) 2-7
6. Kramer B.W., Ladenburger A., Kunzmann S., Speer C.P., Been J.V., van Iwaarden J.F., et al. Intravenous lipopolysaccharide-induced pulmonary maturation and structural changes in fetal sheep. Am J Obstet Gynecol 200 (2009) 195e1 10
7. Lahra M.M., Beeby P.J., and Jeffery H.E. Maternal versus fetal inflammation and respiratory distress syndrome: a 10-year hospital cohort study. Arch Dis Child Fetal Neonatal Ed 94 (2009) F13-F16
8. Kosuge S., Ohkuchi A., Minakami H., Matsubara S., Uchida A., Eguchi Y., et al. Influence of chorioamnionitis on survival and morbidity in singletons live-born at < 32 weeks of gestation. Acta Obstet Gynecol Scand 79 (2000) 861-865
9. Watterberg K.L., Demers L.M., Scott S.M., and Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 97 (1996) 210-215
10. Dempsey E., Chen M.F., Kokottis T., Vallerand D., and Usher R. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol 22 (2005) 155-159
11. Andrews W.W., Goldenberg R.L., Faye-Petersen O., Cliver S., Goepfert A.R., and Hauth J.C. The Alabama Preterm Birth Study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol 195 (2006) 803-808
12. Lee J., Seong H.S., Kim B.J., Jun J.K., Romero R., and Yoon B.H. Evidence to support that spontaneous preterm labor is adaptive in nature: neonatal RDS is more common in "indicated" than in "spontaneous" preterm birth. J Perinat Med 37 (2009) 53-58
13. Been JV, Rours IG, Kornelisse RF, Lima Passos V, Kramer BW, Schneider TA, et al. Histologic chorioamnionitis, fetal involvement and antenatal steroids: effects on neonatal outcome in preterm infants. Am J Obstet Gynecol 2009 Sep 1 [Epub ahead of print].
14. Been J.V., and Zimmermann L.J. Histological chorioamnionitis and respiratory outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed 94 (2009) F218-F225
15. Watterberg K.L., Scott S.M., and Naeye R.L. Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants. Pediatrics 99 (1997) e6
16. Kramer B.W. Antenatal inflammation and lung injury: prenatal origin of neonatal disease. J Perinatol 28 Suppl 1 (2008) S21-S27
17. Van Marter L.J., Dammann O., Allred E.N., Leviton A., Pagano M., Moore M., et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 140 (2002) 171-176
18. Ikegami M., and Jobe A.H. Postnatal lung inflammation increased by ventilation of preterm lambs exposed antenatally to Escherichia coli endotoxin. Pediatr Res 52 (2002) 356-362
19. Ikegami M., Kallapur S.G., and Jobe A.H. Initial responses to ventilation of premature lambs exposed to intra-amniotic endotoxin 4 days before delivery. Am J Physiol Lung Cell Mol Physiol 286 (2004) L573-L579
20. Meyer K.C., and Zimmerman J.J. Inflammation and surfactant. Paediatr Respir Rev 3 (2002) 308-314
21. Zuo Y.Y., Veldhuizen R.A., Neumann A.W., Petersen N.O., and Possmayer F. Current perspectives in pulmonary surfactant: inhibition, enhancement and evaluation. Biochim Biophys Acta 1778 (2008) 1947-1977
22. Been JV, Kornelisse RF, Rours IG, Passos VL, de Krijger RR, Zimmermann LJ. Early postnatal blood pressure in preterm infants: effects of chorioamnionitis and timing of antenatal steroids. Pediatr Res 2009 Aug 5 [Epub ahead of print].
23. Altemeier W.A., Matute-Bello G., Frevert C.W., Kawata Y., Kajikawa O., Martin T.R., et al. Mechanical ventilation with moderate tidal volumes synergistically increases lung cytokine response to systemic endotoxin. Am J Physiol Lung Cell Mol Physiol 287 (2004) L533-L542
24. Tremblay L., Valenza F., Ribeiro S.P., Li J., and Slutsky A.S. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99 (1997) 944-952
25. Chiumello D., Pristine G., and Slutsky A.S. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med 160 (1999) 109-116
26. Laughon M., Allred E.N., Bose C., O'Shea T.M., Van Marter L.J., Ehrenkranz R.A., et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 123 (2009) 1124-1131
27. Merrill J.D., Ballard R.A., Cnaan A., Hibbs A.M., Godinez R.I., Godinez M.H., et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 56 (2004) 918-926
28. Schmidt R., Markart P., Ruppert C., Wygrecka M., Kuchenbuch T., Walmrath D., et al. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res 8 (2007) 55
29. Raymondos K., Leuwer M., Haslam P.L., Vangerow B., Ensink M., Tschorn H., et al. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis. Crit Care Med 27 (1999) 82-89
30. Nakos G., Kitsiouli E.I., Tsangaris I., and Lekka M.E. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS: alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med 24 (1998) 296-303
31. Markart P., Ruppert C., Wygrecka M., Colaris T., Dahal B., Walmrath D., et al. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids. Thorax 62 (2007) 588-594
32. Baker C.S., Evans T.W., Randle B.J., and Haslam P.L. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 353 (1999) 1232-1237
33. Malloy J.L., and Wright J.R. In vivo clearance of surfactant lipids during acute pulmonary inflammation. Respir Res 5 (2004) 8
34. Cogo P.E., Zimmermann L.J., Pesavento R., Sacchetto E., Burighel A., Rosso F., et al. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia. Crit Care Med 31 (2003) 1532-1538
35. Halliday H.L., Tarnow-Mordi W.O., Corcoran J.D., and Patterson C.C. Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child 69 (1993) 276-280
36. Halliday H.L. History of surfactant from 1980. Biol Neonate 87 (2005) 317-322
37. Bohlin K., Jonsson B., Gustafsson A.S., and Blennow M. Continuous positive airway pressure and surfactant. Neonatology 93 (2008) 309-315
38. Lu K.W., Taeusch H.W., Robertson B., Goerke J., and Clements J.A. Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries. Am J Respir Crit Care Med 164 (2001) 1531-1536
39. Cheah F.C., Winterbourn C.C., Darlow B.A., Mocatta T.J., and Vissers M.C. Nuclear factor kappaB activation in pulmonary leukocytes from infants with hyaline membrane disease: associations with chorioamnionitis and Ureaplasma urealyticum colonization. Pediatr Res 57 (2005) 616-623
40. von Bismarck P., Klemm K., Wistadt C.F., Winoto-Morbach S., Uhlig U., Schutze S., et al. Surfactant "fortification" by topical inhibition of nuclear factor-kappaB activity in a newborn piglet lavage model. Crit Care Med 35 (2007) 2309-2318